Abstract:Background: Epigallocatechin gallate (EGCG) has attracted increasing attention due to its beneficial effect on cardiovascular health. The aim of this study was to investigate the underlying mechanism by which EGCG protects against myocardial ischaemia/reperfusion injury (I/RI). Methods: Murine myocardial I/RI and H2O2-induced cardiomyocyte injury models were established to evaluate the therapeutic effects of EGCG. In the myocardial I/RI mouse model, the echocardiographic parameters of ejection fraction (EF) and fraction shortening (FS) levels, infarct size, histological evaluation and transmission electron microscopy (TEM) were used to evaluate cardiac tissue damage and autophagy. MTT assays, TUNEL staining, flow cytometry and immunofluorescence (IF) were used to monitor cell viability, apoptosis and autophagy in vitro. qRT-PCR and western blotting were used to determine the mRNA and protein levels of key molecules, respectively. The epigenetic regulation of DUSP5 was assessed via RNA immunoprecipitation (RIP), RNA pull-down and chromatin immunoprecipitation (ChIP) assays. Results: EGCG significantly improved cardiac function, reduced infarct size, enhanced cell viability and inhibited autophagic activity in both myocardial I/RI mouse models and H2O2-induced cardiomyocyte injury models. Moreover, EGCG suppressed H2O2- or myocardial I/R-increased Gm4419 expression, and Gm4419 overexpression dramatically abolished EGCG-mediated protective effects against myocardial I/RI. Mechanistically, Gm4419 epigenetically suppressed DUSP5 by recruiting EZH2, thus activating ERK1/2 pathway-mediated autophagy. Furthermore, the in vivo experiments further verified that the Gm4419-mediated disruptive effects of EGCG on myocardial I/RI were potentiated by DUSP5 knockdown but attenuated by DUSP5 overexpression. Conclusions: In conclusion, our findings demonstrated that EGCG protected against myocardial I/RI by modulating Gm4419/DUSP5/ERK1/2-mediated autophagy.

Down-regulation of Connexin43 Gap Junction by Serum Deprivation in Human Endothelial Cells Was Improved by (−)-Epigallocatechin Gallate Via ERK MAP Kinase Pathway

Advanced Glycation End Products Upregulates The Expression Of Connexin43 Via Erk Mapk And Pi3k/Akt Pathways In Human Endothelial Cells

Epigallocatechin-3 Gallate, a Green Tea Catechin, Attenuated the Downregulation of the Cardiac Gap Junction Induced by High Glucose in Neonatal Rat Cardiomyocytes

Upregulation of Connexin43 by Glucose Deprivation in H9c2 Cells Via the Extracellular Signal‑regulated Kinase/mitogen‑activated Protein Kinase Signaling Pathway

[Epigallocatechin Gallate Attenuates the Expression of Regulated Upon Activation Normal T Cell Expressed and Secreted Induced by Lipopolysaccharide in Human Retinal Endothelial Cells].

Epigallocatechin-3-gallate Attenuates Lipopolysaccharide-Induced Inflammation in Human Retinal Endothelial Cells

Epigallocatechin-3-gallate Ameliorates LPS-induced Inflammation by Inhibiting the Phosphorylation of Akt and ERK Signaling Molecules in Rat H9c2 Cells

Epigallocatechin-3-gallate Attenuates Microcystin-Lr Induced Oxidative Stress and Inflammation in Human Umbilical Vein Endothelial Cells.

Epigallocatechin-3-Gallate Ameliorates Angiotensin II-Induced Oxidative Stress and Apoptosis in Human Umbilical Vein Endothelial Cells through the Activation of Nrf2/Caspase-3 Signaling

(-)-Epigallocatechin-3-gallate Protects Against Uric Acid-Induced Endothelial Dysfunction in Human Umbilical Vein Endothelial Cells

Pro-apoptotic and migration-suppressing potential of EGCG, and the involvement of AMPK in the p53-mediated modulation of VEGF and MMP-9 expression

(−)-Epigallocatechin gallate inhibits endotoxin-induced expression of inflammatory cytokines in human cerebral microvascular endothelial cells

EGCG Attenuates Atherosclerosis Through the Jagged-1/Notch Pathway.

Epigallocatechin-3-gallate Attenuates Microcystin-Lr-induced Apoptosis in Human Umbilical Vein Endothelial Cells Through Activation of the NRF2/HO-1 Pathway.

EGCG protects against myocardial I/RI by regulating lncRNA Gm4419-mediated epigenetic silencing of the DUSP5/ERK1/2 axis

Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2

Real Time Monitoring of Inhibition of Adipogenesis and Angiogenesis by (−)-Epigallocatechin-3-gallate in 3T3-L1 Adipocytes and Human Umbilical Vein Endothelial Cells

Gap26 Inhibited Angiogenesis Through the Β-Catenin-ve-cadherin-vegfr2-erk Signaling Pathway.

(-)-Epigallocatechin Gallate Inhibits Endothelin-1-induced C-reactive Protein Production in Vascular Smooth Muscle Cells.

EGCG protects against homocysteine-induced human umbilical vein endothelial cells apoptosis by modulating mitochondrial-dependent apoptotic signaling and PI3K/Akt/eNOS signaling pathways

Effects of EGCG on the Expression of CTGF in HK-2 Cells